P–325 The impact of letrozole on endometrial thickness in IVF cycles

来曲唑 保持生育能力 医学 妇科 子宫内膜癌 生育率 胚胎移植 乳腺癌 妊娠率 怀孕 产科 癌症 内科学 三苯氧胺 生物 人口 环境卫生 遗传学
作者
Jacob Ruiter‐Ligeti,Suha Arab,William Buckett
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:36 (Supplement_1)
标识
DOI:10.1093/humrep/deab130.324
摘要

Abstract Study question Does daily administration of letrozole during IVF stimulation affect endometrial thickness ? Summary answer Patients treated with letrozole during fresh IVF cycles had a thinner endometrium on the day of trigger compared to patients who did not receive letrozole. What is known already Letrozole supplementation is commonly used during fertility preservation for breast cancer patients to reduce peak estrogen levels with no adverse effects on embryo outcomes. Studies in poor responders have found that letrozole use resulted in a shorter duration of stimulation and a lower total dose of gonadotropin, with no detrimental effect on IVF outcomes. In normal responders, studies have shown an increase in blastocysts obtained, but have not yet shown an increase in clinical pregnancy rates. There is concern that when a fresh embryo transfer is planned letrozole use may negatively affect endometrial thickness and subsequently diminish pregnancy rates. Study design, size, duration In a retrospective cohort study between January 2009 and June 2019 at a single academic fertility center, we compared the endometrial thickness in 97 cancer patients who underwent IVF-fertility preservation with daily letrozole use to 158 cancer patients who underwent IVF-fertility preservation without letrozole. Participants/materials, setting, methods All women diagnosed with cancer were referred for fertility preservation prior to gonadotoxic treatment exposure and were less than 40 years old at the time of oocyte retrieval. All patients who received letrozole started on day one of stimulation and continued until the day of oocyte retrieval. The primary outcome was endometrial thickness on the day of trigger. The secondary outcomes were number of oocytes retrieved, number of MII retrieved, and maximal estradiol level. Main results and the role of chance During the study period, 336 cancer patients underwent fertility preservation. Eighty-one patients were excluded; 50 because they had an intrauterine device or were on long term oral contraceptives and 31 because endometrial thickness was not documented. Of the remaining 255 patients, 86 had breast cancer, 95 had a hematological cancer and 74 had various other cancers. Ninety-seven cancer patients treated with letrozole were compared to 158 cancer patients who did not receive letrozole. Patients who received letrozole were significantly older (34 vs 28yrs, P < 0.0001). There were no significant differences in baseline characteristics such as BMI, AFC nor in the total duration for stimulation. Endometrial thickness on the day of trigger was significantly less in letrozole treated patients (8 vs 9mm, P < 0.003). There were no significant differences in total number of oocytes retrieved (12.5 vs 11, P = 0.126) nor in the number of mature oocytes (8 vs 8, P = 0.312). Patients in the letrozole group received a higher total gonadotropin dose (2680IU vs 1980IU, P = 0.016). The maximum estradiol level was significantly lower in patients treated with letrozole (1068 vs 3838ml/dl, P = <0.0001). A regression analysis showed that using letrozole during stimulation decreased the endometrial thickness by 0.81mm (CI –1.37 to –0.253, P = 0.005). Limitations, reasons for caution The retrospective nature of this study could have introduced selection and misinformation bias. We report on cancer patients where all oocytes or embryos were vitrified. Without fresh embryo transfer data, it is unclear if a thinner endometrium due to letrozole will effect the implantation or pregnancy rate. Wider implications of the findings: As the use of letrozole expands beyond cancer patients and poor responders, it is important to understand the impact on the endometrium. This study shows that letrozole reduces endometrial thickness. However, the effect on endometrial function remains unknown. Further study is needed before letrozole can be used with fresh transfers. Trial registration number 2020–6370

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
噜噜噜噜噜完成签到,获得积分10
刚刚
赵慧霞关注了科研通微信公众号
刚刚
炎魔之王拉格纳罗斯完成签到,获得积分10
1秒前
内向苡完成签到,获得积分10
2秒前
以筱发布了新的文献求助10
4秒前
bhkwxdxy完成签到,获得积分10
5秒前
悦耳虔纹完成签到 ,获得积分10
5秒前
xx完成签到,获得积分10
5秒前
大气灵枫完成签到,获得积分10
5秒前
妮妮完成签到,获得积分10
6秒前
8秒前
Struggle完成签到 ,获得积分10
9秒前
9秒前
秦兴虎完成签到,获得积分10
10秒前
Drew11完成签到,获得积分10
10秒前
风趣青槐完成签到,获得积分10
12秒前
科隆龙完成签到,获得积分10
13秒前
13秒前
饱满一手完成签到 ,获得积分10
13秒前
99完成签到,获得积分10
15秒前
枕星发布了新的文献求助10
15秒前
drlq2022完成签到,获得积分10
16秒前
王山完成签到,获得积分10
17秒前
自觉寒梦完成签到,获得积分10
18秒前
ding应助缥缈一刀采纳,获得10
18秒前
pakiorder发布了新的文献求助10
18秒前
专心搞学术完成签到,获得积分10
18秒前
bkagyin应助zzcherished采纳,获得10
20秒前
你怎么这么可爱啊完成签到,获得积分10
20秒前
21秒前
研友_Lmg1gZ完成签到,获得积分10
21秒前
Crazyer完成签到,获得积分10
21秒前
Shuey完成签到,获得积分10
22秒前
XXXXH完成签到,获得积分10
22秒前
Z可完成签到 ,获得积分10
23秒前
momo123完成签到 ,获得积分10
23秒前
高兴的书竹完成签到 ,获得积分10
24秒前
mp5完成签到,获得积分10
25秒前
薯条一克完成签到 ,获得积分10
25秒前
zzcherished完成签到,获得积分10
26秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029